Remedy Robotics is a medical technology company developing robotic systems for endovascular intervention. Its proprietary technology combines robotics, machine learning, and advanced computer vision to help physicians perform highly precise endovascular procedures and expand access to life-saving stroke and cardiovascular care. Initially focused on neurovascular intervention, Remedy is addressing the limited availability of specialized treatment for time-critical cardiovascular emergencies, with the long-term goal of enabling expert intervention regardless of patient location. Headquartered in San Francisco, Remedy is backed by DCVC, Blackbird, and Tony Fadell's Build Collective, among others.
We’re looking for a motivated and experienced technician to build electromechanical hardware for novel, life saving surgical robots.

Remedy Robotics exists to bring flawless, immediate, endovascular intervention (EI)—treatment for stroke, heart attack, bleeding, aneurysmal disease, pulmonary embolism and more— to every patient worldwide. Remedy is the only company in the world to have performed:
- Completely robotic neurointerventional procedures in humans from start to finish.
- Completely remote robotic neurointerventional procedures in humans from from start to finish.
- Autonomous endovascular navigation.
A few key principles underlie our work. We strongly believe that:
- EI is optimizable. Tool movements should be deliberate and efficient. Procedures should be fast and effective. Complications should be avoided without exception.
- All patients at elite US institutions deserve access to flawless EI without delay. But so do all patients at smaller US community hospitals. And so do all patients in Kinshasa and Port Moresby and Alice Springs and anywhere in the world.
- The world's finest technology and technologists should focus on advancing our health and wellbeing. They belong at Remedy Robotics.